Cover Image

Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?

Objectives: To date limited information about cefiderocol use is provided by real life studies. Our aim is to evaluate characteristics and outcome of patients with Gram-negative infections with limited therapeutic options treated with cefiderocol in combination or monotherapy. Methods: We retrospect...

Full description

Saved in:

Bibliographic Details
Main Authors:	Silvia Corcione (Author), Ilaria De Benedetto (Author), Simone Mornese Pinna (Author), Davide Vita (Author), Tommaso Lupia (Author), Giorgia Montrucchio (Author), Luca Brazzi (Author), Francesco Giuseppe De Rosa (Author)
Format:	Book
Published:	Elsevier, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series
by: Simone Mornese Pinna, et al.
Published: (2022)

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022)

The solution to drug resistance of Gram-negative bacteria - Cefiderocol
by: Magdalena Kołodziej, et al.
Published: (2023)

Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
by: Cristina Kirkegaard-Biosca, et al.
Published: (2024)

The Use of Cefiderocol in Gram-Negative Bacterial Infections at International Medical Center, Jeddah, Saudi Arabia
by: Reham Kaki, et al.
Published: (2024)

Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
by: Davide Fiore Bavaro, et al.
Published: (2021)

Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it's even arrived?
by: Chiara Russo, et al.
Published: (2024)

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Chuanhai Wang, et al.
Published: (2022)

In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17
by: Esther Wohlfarth, et al.
Published: (2023)

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
by: Saoussen Oueslati, et al.
Published: (2022)

Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Frontiers Production Office
Published: (2022)

Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art
by: Alessio Sollima, et al.
Published: (2024)

Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms
by: Gabriele Bianco, et al.
Published: (2022)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
by: Tommaso Lupia, et al.
Published: (2022)

Real-world experience with cefiderocol therapy for Pseudomonas aeruginosa and other multidrug resistant gram-negative infections within the Veterans Health Administration, 2019-2022
by: Andrew Chou, et al.
Published: (2023)

Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria
by: Marta Palombo, et al.
Published: (2023)

Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review
by: Paul-Henri Wicky, et al.
Published: (2023)

Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis
by: Carlos Risco-Risco, et al.
Published: (2024)

Beta Lactams Plus Daptomycin Combination Therapy for Infective Endocarditis: An Italian National Survey (BADAS)
by: Silvia Corcione, et al.
Published: (2022)

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by: Onyinyechi Obidiro, et al.
Published: (2023)

Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review
by: Ilaria De Benedetto, et al.
Published: (2024)

Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria
by: Hyejin Cho, et al.
Published: (2022)

Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review
by: Lorenzo Chiusaroli, et al.
Published: (2022)

Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak
by: Giovanna Travi, et al.
Published: (2024)

Gram-Negative Bacterial Lysins
by: Chandrabali Ghose, et al.
Published: (2020)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
by: Michela Padovani, et al.
Published: (2023)

Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
by: Claudia Alteri, et al.
Published: (2024)

Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection
by: Xueyong Li, et al.
Published: (2022)

Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry
by: Tommaso Lupia, et al.
Published: (2022)

Antimicrobial potential of Streptomyces sp. to the Gram positive and Gram negative pathogens
by: Mysoon Al-Ansari, et al.
Published: (2019)

Activity of Specialized Biomolecules against Gram-Positive and Gram-Negative Bacteria
by: Tânia D. Tavares, et al.
Published: (2020)

Gram-Negative Toe Web Infections
by: Kelita Waterton, et al.
Published: (2024)

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
by: Helen Giamarellou, et al.
Published: (2022)

Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
by: A Khorshidi, et al.
Published: (2010)

Imipenem Resistance Among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
by: AR Sharif, et al.
Published: (2010)

Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
by: Andrea Vila Domínguez, et al.
Published: (2020)

Post-neurosurgical meningitis; gram negative bacilli vs. gram positive cocci
by: Mehdi Zeinalizadeh, et al.
Published: (2022)

Protective Effect of Procyanidin-Rich Grape Seed Extract against Gram-Negative Virulence Factors
by: Roberta Maria Nicolosi, et al.
Published: (2023)

Infection Control in the Era of COVID-19: A Narrative Review
by: Nour Shbaklo, et al.
Published: (2021)

Aggregatibacter actinomycetemcomitans-Gram-Negative Bacterial Pathogen
Published: (2021)